BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7801046)

  • 1. [Type II Charcot-Marie-Tooth and dopa-sensitive Parkinson disease].
    Tranchant C; Ruh D; Warter JM
    Rev Neurol (Paris); 1994; 150(1):72-4. PubMed ID: 7801046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Charcot-Marie-Tooth disease type II and dopa-sensitive Parkinson syndrome].
    Dupuis JM; Brucher JM
    Rev Neurol (Paris); 1994 Oct; 150(10):740-1. PubMed ID: 7792485
    [No Abstract]   [Full Text] [Related]  

  • 3. Leber's optic neuropathy and Charcot-Marie-Tooth disease. Report of a case.
    McCluskey DJ; O'Connor PS; Sheehy JT
    J Clin Neuroophthalmol; 1986 Jun; 6(2):76-81. PubMed ID: 2942573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conduction system disease and Charcot-Marie-Tooth syndrome].
    Rosselot E; Brinck G
    Rev Med Chil; 1989 Aug; 117(8):914-7. PubMed ID: 2519453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurophysiology and molecular genetics of Charcot-Marie-Tooth type 1 neuropathy in Croatian children: follow-up study.
    Barisić N; Mihatov I
    Croat Med J; 2000 Sep; 41(3):306-13. PubMed ID: 10962051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large family with Charcot-Marie-Tooth Type 1a and Type 2 diabetes mellitus.
    Koç F; Sarica Y; Yerdelen D; Baris I; Battaloglu E; Sert M
    Int J Neurosci; 2006 Feb; 116(2):103-14. PubMed ID: 16393877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1 associated with Charcot-Marie-Tooth type 1A.
    Koc F; Guzel AI
    J Dermatol; 2009 May; 36(5):306-11. PubMed ID: 19383003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system signs in X-linked Charcot-Marie-Tooth disease after hyperventilation.
    Srinivasan J; Leventer RJ; Kornberg AJ; Dahl HH; Ryan MM
    Pediatr Neurol; 2008 Apr; 38(4):293-5. PubMed ID: 18358413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [L-dopa in the treatment of the Parkinsonian syndrome].
    Apostol-Pruskauer B; Voiculescu V
    Neurol Psihiatr Neurochir; 1973; 18(6):539-49. PubMed ID: 4790486
    [No Abstract]   [Full Text] [Related]  

  • 10. Charcot-Marie-Tooth type 1a in a child with Long QT syndrome.
    Losito L; De Rinaldis M; Gennaro L; Priori SG; Bloise R; Bassi MT; Bresolin N; Trabacca A
    Eur J Paediatr Neurol; 2009 Sep; 13(5):459-62. PubMed ID: 18799333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Charcot-Marie-Tooth disease and stroke].
    Sinanović O; Dimitrijević J; Hudić J; Hrnjica M
    Med Pregl; 1992; 45(3-4):119-23. PubMed ID: 16104087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.
    Carter GT; Han JJ; Mayadev A; Weiss MD
    Am J Hosp Palliat Care; 2006; 23(5):412-6. PubMed ID: 17060310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of the parkinsonian syndrome with L-dopa and amantadine].
    Pendefunda GH; Pollingher B; Stefanache F; Gavril A; Oprişan C; Merling M; Nemţeanu E; Ciuntu M; Koropitzer I
    Neurol Psihiatr Neurochir; 1973; 18(6):559-68. PubMed ID: 4790488
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of Parkinsonian syndrome using L-dopa. Current state and problems].
    Fischer PA
    Nervenarzt; 1974 Dec; 45(12):617-27. PubMed ID: 4614096
    [No Abstract]   [Full Text] [Related]  

  • 15. [Charcot-Marie-Tooth disease and glomerular nephropathy].
    Deniau F; Guillot M; Plus A; Leveque C; Gubler MC; Broyer M; Aicardi J; Lechevalier B
    Arch Fr Pediatr; 1986 Dec; 43(10):791-3. PubMed ID: 3827511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral sudden sensorineural hearing loss caused by Charcot-Marie-Tooth disease.
    Papadakis CE; Hajiioannou JK; Kyrmizakis DE; Bizakis JG
    J Laryngol Otol; 2003 May; 117(5):399-401. PubMed ID: 12803792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charcot-Marie-Tooth disease associated with hip dysplasia: a case report.
    Cucuzzella TR; Guille JT; MacEwen GD
    Del Med J; 1996 Jun; 68(6):305-7. PubMed ID: 8698139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease.
    LeGuern E; Gouider R; Mabin D; Tardieu S; Birouk N; Parent P; Bouche P; Brice A
    Ann Neurol; 1997 Jan; 41(1):104-8. PubMed ID: 9005872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anesthetic management for laparoscopic surgery in a patient with Charcot-Marie-Tooth disease].
    Niiyama Y; Kanaya N; Namiki A
    Masui; 2003 May; 52(5):524-6. PubMed ID: 12795137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma and Charcot-Marie-Tooth disease.
    Greene MH; Mead GD; Reimer RR; Bergfeld WF; Fraumeni JF
    Am J Med Genet; 1980; 5(1):69-71. PubMed ID: 7395902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.